Related references
Note: Only part of the references are listed.Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia
Wen Yi Ding et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study
S. H. Kardaun et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese
Ying-Kit Cheung et al.
EPILEPSIA (2013)
Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome
Chun-Yu Wei et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
Kongkiat Kulkantrakorn et al.
PAIN PRACTICE (2012)
Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
Sae-Hoon Kim et al.
EPILEPSY RESEARCH (2011)
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
Takeshi Ozeki et al.
HUMAN MOLECULAR GENETICS (2011)
Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
Choong-Chor Chang et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome
Tai-Ming Ko et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations
Faviel F. Gonzalez-Galarza et al.
NUCLEIC ACIDS RESEARCH (2011)
Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland
Qian Wang et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
ALDEN, an Algorithm for Assessment of Drug Causality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case-Control Analysis
B. Sassolas et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
Wichittra Tassaneeyakul et al.
EPILEPSIA (2010)
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
Shuen-Iu Hung et al.
PHARMACOGENOMICS (2010)
Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians
Timir Y. Mehta et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2009)
HLA-B*15 subtypes in Burmese population by sequence-based typing
C. Kongmaroeng et al.
TISSUE ANTIGENS (2009)
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
Chaichon Locharernkul et al.
EPILEPSIA (2008)
Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
Maja Mockenhaupt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in han Chinese
Celeste B. L. Man et al.
EPILEPSIA (2007)
Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?
S. H. Kardaun et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Clinical heterogeneity of drug hypersensitivity
JC Roujeau
TOXICOLOGY (2005)
Share Paper
